The role of soluble CD40L in immunosuppression
We have recently performed the first comprehensive study of the potential immunosuppressive role of soluble CD40L (sCD40L). In addition, we demonstrated that serum sCD40L can potentially be used as an indicator of response to anticancer therapy, and/or to better identify those patients who would hav...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Landes Bioscience
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583923/ |
| id |
pubmed-3583923 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-35839232013-03-11 The role of soluble CD40L in immunosuppression Schlom, Jeffrey Jochems, Caroline Gulley, James L. Huang, Jianping Author's View We have recently performed the first comprehensive study of the potential immunosuppressive role of soluble CD40L (sCD40L). In addition, we demonstrated that serum sCD40L can potentially be used as an indicator of response to anticancer therapy, and/or to better identify those patients who would have best chances to benefit from tumor-targeting vaccines or other therapeutic modalities. Landes Bioscience 2013-01-01 /pmc/articles/PMC3583923/ /pubmed/23483661 http://dx.doi.org/10.4161/onci.22546 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Schlom, Jeffrey Jochems, Caroline Gulley, James L. Huang, Jianping |
| spellingShingle |
Schlom, Jeffrey Jochems, Caroline Gulley, James L. Huang, Jianping The role of soluble CD40L in immunosuppression |
| author_facet |
Schlom, Jeffrey Jochems, Caroline Gulley, James L. Huang, Jianping |
| author_sort |
Schlom, Jeffrey |
| title |
The role of soluble CD40L in immunosuppression |
| title_short |
The role of soluble CD40L in immunosuppression |
| title_full |
The role of soluble CD40L in immunosuppression |
| title_fullStr |
The role of soluble CD40L in immunosuppression |
| title_full_unstemmed |
The role of soluble CD40L in immunosuppression |
| title_sort |
role of soluble cd40l in immunosuppression |
| description |
We have recently performed the first comprehensive study of the potential immunosuppressive role of soluble CD40L (sCD40L). In addition, we demonstrated that serum sCD40L can potentially be used as an indicator of response to anticancer therapy, and/or to better identify those patients who would have best chances to benefit from tumor-targeting vaccines or other therapeutic modalities. |
| publisher |
Landes Bioscience |
| publishDate |
2013 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583923/ |
| _version_ |
1611958110974377984 |